Association study between BDNF C-281A polymorphism and paranoid schizophrenia in Polish population

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Brain-derived neurotrophic factor (BDNF) is implicated in schizophrenia.
• The BDNF C-281A polymorphism (rs28383487) affects promoter activity in hippocampal neurons.
• Previous research suggests BDNF's role in schizophrenia pathogenesis.

Purpose of the Study:

• To investigate the influence of BDNF C-281A alleles and genotypes on the development and clinical course of paranoid schizophrenia.
• To examine associations with age of onset, suicidal behavior, and psychopathology.
• To conduct haplotype analysis with the val66met BDNF polymorphism.

Main Methods:

• Case-control study comparing schizophrenic patients and healthy controls.
• Genotyping for BDNF C-281A and val66met polymorphisms.
• Psychopathology assessment using the Positive and Negative Syndrome Scale (PANSS).
• Haplotype analysis to assess linkage disequilibrium.

Main Results:

• No significant differences in genotype or allele distribution between patients and controls.
• No significant differences in PANSS scores across genotype groups.
• A significant association between the BDNF C-281A C/A genotype and a later age of onset in male paranoid schizophrenia patients (p < 0.01).
• Strong linkage disequilibrium (D' = 0.9875) between C-281A and val66met polymorphisms.
• A trend towards lower frequency of the Met-C haplotype in the schizophrenia group.

Conclusions:

• The BDNF C-281A polymorphism may influence the age of onset in paranoid schizophrenia, particularly in men.
• The C-281A and val66met polymorphisms are in strong linkage disequilibrium.
• Further research is needed to clarify the specific role of BDNF polymorphisms in schizophrenia etiology and clinical presentation.